{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:39:53Z","timestamp":1793313593573,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijid.2026.108784","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T05:46:53Z","timestamp":1778392013000},"page":"108784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["RSV vaccination in immunocompromised adults"],"prefix":"10.1016","volume":"169","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1218-9432","authenticated-orcid":false,"given":"Paul","family":"Loubet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slim","family":"Fourati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108784_bib0001","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0105-2022","article-title":"Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries","volume":"31","author":"Nguyen-Van-Tam","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ijid.2026.108784_bib0002","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00042-19","article-title":"Community-acquired respiratory viruses in transplant patients: diversity, impact, unmet clinical needs","volume":"32","author":"Ison","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2026.108784_bib0003","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108784_bib0004","doi-asserted-by":"crossref","first-page":"595\u2011608","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108784_bib0005","doi-asserted-by":"crossref","first-page":"2233\u201144","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108784_bib0006","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/cid\/ciae550","article-title":"Bivalent RSVpreF vaccine in adults 18 to <60 years old with high-risk conditions","volume":"80","author":"Davis","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108784_bib0007","doi-asserted-by":"crossref","first-page":"202\u20119","DOI":"10.1093\/cid\/ciad471","article-title":"Respiratory syncytial virus prefusion F protein vaccine is efficacious in older adults with underlying medical conditions","volume":"78","author":"Feldman","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108784_bib0008","doi-asserted-by":"crossref","first-page":"1547\u201159","DOI":"10.1016\/S0140-6736(24)01738-0","article-title":"Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis","volume":"404","author":"Payne","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2026.108784_bib0009","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/vaccines13030328","article-title":"Immunogenicity and safety of the bivalent respiratory syncytial virus prefusion F subunit vaccine in immunocompromised or renally impaired adults","volume":"13","author":"Almeida","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.ijid.2026.108784_bib0010","first-page":"429\u201132","article-title":"Antibody response to respiratory syncytial virus vaccination in immunocompromised persons","volume":"333","author":"Karaba","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2026.108784_bib0011","doi-asserted-by":"crossref","first-page":"161\u20118","DOI":"10.1016\/j.cmi.2025.09.013","article-title":"Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study","volume":"32","author":"Hall","year":"2026","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2026.108784_bib0012","doi-asserted-by":"crossref","first-page":"1452\u201160","DOI":"10.1016\/j.ajt.2025.03.025","article-title":"Respiratory syncytial virus prefusion F3 vaccine in lung transplant recipients elicits CD4+ T cell response in all vaccinees","volume":"25","author":"Havlin","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijid.2026.108784_bib0013","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/vaccines13040398","article-title":"Neutralizing antibody response to the AreXvy respiratory syncytial virus vaccine in lung transplant recipients: assessment against reference and seasonal strains","volume":"13","author":"Levy","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.ijid.2026.108784_bib0014","article-title":"Cellular and humoral immunogenicity of respiratory syncytial virus vaccination in solid organ transplant recipients","author":"Bronder","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijid.2026.108784_bib0015","doi-asserted-by":"crossref","first-page":"1478\u201180","DOI":"10.1001\/jama.2025.16744","article-title":"Respiratory syncytial virus vaccination in adult allogeneic hematopoietic cell transplant recipients","volume":"334","author":"L\u00f6tscher","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2026.108784_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.33828","article-title":"Respiratory syncytial virus vaccination in allogeneic hematopoietic stem cell transplant recipients","volume":"8","author":"Redjoul","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijid.2026.108784_bib0017","doi-asserted-by":"crossref","first-page":"sfag093","DOI":"10.1093\/ckj\/sfag093","article-title":"Immunogenicity and reactogenicity of the adjuvanted respiratory syncytial virus vaccine in patients with chronic kidney disease","author":"Radun","year":"2026","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ijid.2026.108784_bib0018","first-page":"ciag108","article-title":"RSV vaccination in solid organ transplant recipients: interim findings from a phase 3 trial of mRNA-1345","author":"Mayer","year":"2026","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108784_bib0019","doi-asserted-by":"crossref","first-page":"311\u20117","DOI":"10.1111\/ajt.12122","article-title":"Vaccination in solid organ transplantation","volume":"13","author":"Danziger-Isakov","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijid.2026.108784_bib0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.8322","article-title":"Effectiveness and safety of respiratory syncytial virus vaccine for US adults aged 60 years or older","volume":"8","author":"Fry","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijid.2026.108784_bib0021","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.15775","article-title":"RSV vaccine effectiveness against hospitalization among US adults 60 years and older","author":"Surie","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2026.108784_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.50832","article-title":"Estimated vaccine effectiveness for respiratory syncytial virus-related lower respiratory tract disease","volume":"7","author":"Tartof","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijid.2026.108784_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00796-5","article-title":"Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study","author":"Bajema","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108784_bib0024","article-title":"Durability of respiratory syncytial virus vaccine effectiveness among US veterans","author":"Bajema","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ijid.2026.108784_bib0025","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1001\/jama.2025.15896","article-title":"RSV vaccine effectiveness against hospitalization among US adults aged 60 years or older during 2 seasons","volume":"334","author":"Surie","year":"2025","journal-title":"JAMA"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226004194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226004194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:43:58Z","timestamp":1781577838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226004194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":25,"alternative-id":["S1201971226004194"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108784","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RSV vaccination in immunocompromised adults","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108784"}}